Patents by Inventor Traci T. Goodchild

Traci T. Goodchild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recovery of tissue function following administration of B cells to injured tissue
    Patent number: 8603463
    Abstract: The present invention relates generally to systems and methods of enhancing recovery of function of injured tissue through administration of a composition comprising a relatively pure populations of B lymphocyte cells in a pharmaceutically acceptable carrier to the injured tissue. Kits are provided to aid in purification of B cells from heterogeneous mixtures of cells and administration of B cells to injured tissue.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: December 10, 2013
    Assignee: Holy Cross Hospital, Inc.
    Inventors: Mark C. Poznansky, Traci T. Goodchild, Mark T. Ungs, Nicolas A. F. Chronos, Nadine Weich
  • Recovery of Tissue Function Following Administration of B Cells to Injured Tissue
    Publication number: 20100266561
    Abstract: The present invention relates generally to systems and methods of enhancing recovery of function of injured tissue through administration of a composition comprising a relatively pure populations of B lymphocyte cells in a pharmaceutically acceptable carrier to the injured tissue. Kits are provided to aid in purification of B cells from heterogeneous mixtures of cells and administration of B cells to injured tissue.
    Type: Application
    Filed: March 23, 2010
    Publication date: October 21, 2010
    Applicant: ACTx, Inc.
    Inventors: Mark C. Poznansky, Traci T. Goodchild, Mark T. Ungs, Nicolas A.F. Chronos, Nadine Weich
  • Recovery of tissue function following administration of B cells to injured tissue
    Patent number: 7695712
    Abstract: The present invention relates generally to systems and methods of enhancing recovery of function of injured tissue through administration of a composition comprising a relatively pure populations of B lymphocyte cells in a pharmaceutically acceptable carrier to the injured tissue. Kits are provided to aid in purification of B cells from heterogeneous mixtures of cells and administration of B cells to injured tissue.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: April 13, 2010
    Assignee: ACTX, Inc.
    Inventors: Mark C. Poznansky, Traci T. Goodchild, Mark T. Ungs, Nicholas A. F. Chronos, Nadine Weich